| Literature DB >> 24716709 |
Louis S Matza1, Kristina S Boye, David H Feeny, Joseph A Johnston, Lee Bowman, Jessica B Jordan.
Abstract
BACKGROUND: The purpose of this study was to examine the effect of caregiver status on time trade-off (TTO) and standard gamble (SG) health state utility scores. Respondents were categorized as caregivers if they reported that either children or adults depended on them for care.Entities:
Mesh:
Year: 2014 PMID: 24716709 PMCID: PMC3996201 DOI: 10.1186/1477-7525-12-48
Source DB: PubMed Journal: Health Qual Life Outcomes ISSN: 1477-7525 Impact factor: 3.186
Data sources for the current secondary analysis
| 4 | 3 | 16 | |
| Osteoarthritis: three severity levels, plus one adverse event | Adult ADHD: responder, non-responder, untreated | Schizophrenia with a range of treatment-related adverse events | |
| TTO, SG | TTO | TTO | |
| London (UK) | London and Edinburgh (UK) | San Francisco (US) | |
| November 2011 | October 2012 | April-May 2012 | |
| | | | |
| Total | 80 | 158 | 126 |
| Caregivers | 30 | 47 | 29 |
| Non-caregivers | 50 | 111 | 97 |
TTO = Time trade-off; SG = Standard gamble; UK = United Kingdom; US = United States; ADHD = Attention deficit/hyperactivity disorder.
Demographic characteristics
| 48.3 (11.5) | 46.7 (15.9) | 0.64 | 44.9 (11.1) | 47.9 (15.6) | 0.23 | 48.9 (11.2) | 49.7 (16.9) | 0.82 | |
| | | | | | | | | | |
| Male | 20 (66.7%) | 21 (42.0%) | 0.03 | 15 (31.9%) | 65 (58.6%) | <0.01 | 12 (41.4%) | 48 (49.5%) | 0.44 |
| Female | 10 (33.3%) | 29 (58.0%) | | 32 (68.1%) | 46 (41.4%) | | 17 (58.6%) | 49 (50.5%) | |
| | | | | | | | | | |
| White | 15 (50.0%) | 35 (70.0%) | 0.07 | 41 (87.2%) | 91 (82.0%) | 0.42 | 10 (34.5%) | 58 (59.8%) | 0.02 |
| Other | 15 (50.0%) | 15 (30.0%) | | 6 (12.8%) | 20 (18.0%) | | 19 (65.5%) | 39 (40.2%) | |
| | | | | | | | | | |
| Single | 8 (26.7%) | 29 (58.0%) | 0.02 | 10 (21.3%) | 54 (48.6%) | <0.01 | 9 (31.0%) | 59 (60.8%) | 0.02 |
| Married/Living with partner | 11 (36.7%) | 12 (24.0%) | | 26 (55.3%) | 35 (31.5%) | | 8 (27.6%) | 13 (13.4%) | |
| Divorced/Separated/Widowed | 11 (36.7%) | 9 (18.0%) | | 11 (23.4%) | 22 (19.8%) | | 12 (41.4%) | 25 (25.8%) | |
| | | | | | | | | | |
| Full-time work | 8 (26.7%) | 12 (24.0%) | 0.12 | 17 (36.2%) | 35 (31.5%) | 0.11 | 7 (24.1%) | 16 (16.5%) | 0.15 |
| Part-time work | 10 (33.3%) | 18 (36.0%) | | 16 (34.0%) | 24 (21.6%) | | 12 (41.4%) | 24 (24.7%) | |
| Unemployed | 1 (3.3%) | 10 (20.0%) | | 2 (4.3%) | 17 (15.3%) | | 3 (10.3%) | 17 (17.5%) | |
| Other | 11 (36.7%) | 10 (20.0%) | | 12 (25.5%) | 35 (31.5%) | | 7 (24.1%) | 40 (41.2%) | |
| | | | | | | | | | |
| No university degree | 16 (53.3%) | 25 (50.0%) | 0.77 | 34 (72.3%) | 64 (57.7%) | 0.08 | 14 (48.3%) | 44 (45.4%) | 0.78 |
| University or postgraduate degree | 14 (46.7%) | 25 (50.0%) | 13 (27.7%) | 47 (42.3%) | 15 (51.7%) | 53 (54.6%) | |||
*For Study 1, other ethnicity includes 13 Black, 8 Asian, and 9 other races. For Study 2, other ethnicity includes 7 Black, 8 Asian, 1 Chinese and 10 mixed races. For Study 3, other ethnicity includes 24 Black, 10 Hispanic/Latino, 10 Asian, 5 Hawaiian/Pacific Islander and 9 other races.
†For Study 1, other employment includes 3 homemakers, 2 students, 15 retired and 1 disabled. For Study 2, other employment includes 8 homemakers, 9 students, 27 retired, and 3 disabled. For Study 3, other employment includes 3 homemakers, 8 students, 15 retired, 19 disabled and 1 other.
‡P-values are for the comparison between caregivers and non-caregivers. Continuous variables were compared with t-tests, and categorical variables were compared with chi-square analysis.
Frequency and percentage of respondents with values less than 0.95(Study 1)
| | | | |
| HS A: Mild Osteoarthritis | 7 (23.3%) | 23 (46.0%) | 0.04 |
| HS B: Moderate Osteoarthritis | 12 (40.0%) | 31 (62.0%) | 0.06 |
| HS C: Severe Osteoarthritis | 21 (70.0%) | 46 (92.0%) | < 0.01 |
| HS D: Moderate Osteoarthritis + AE | 14 (46.7%) | 34 (68.0%) | 0.06 |
| | | | |
| HS A: Mild Osteoarthritis | 5 (17.2%) | 9 (18.4%) | 0.90 |
| HS B: Moderate Osteoarthritis | 9 (31.0%) | 16 (32.7%) | 0.88 |
| HS C: Severe Osteoarthritis | 20 (69.0%) | 40 (81.6%) | 0.20 |
| HS D: Moderate Osteoarthritis + AE | 11 (37.9%) | 20 (40.8%) | 0.80 |
1Values less than 0.95 indicate willingness to trade in time trade-off choices and willingness to gamble in standard gamble choices. For the descriptive analyses in this table, ratings worse than dead were categorized as less than 0.95.
2Based on chi-square analyses comparing caregivers and non-caregivers.
HS = Health state.
AE = Adverse event.
Frequency and percentage of respondents with TTO utility values less than 0.95(Studies 2 and 3)
| | | | |
| A. Adult ADHD, receiving treatment, responder | 24 (51.1%) | 65 (58.6%) | 0.39 |
| B. Adult ADHD, receiving treatment, non-responder | 33 (70.2%) | 86 (77.5%) | 0.33 |
| C. Adult ADHD, untreated | 34 (72.3%) | 88 (79.3%) | 0.34 |
| | | | |
| A. Basic HS (stable schizophrenia, no adverse events) | 20 (69.0%) | 73 (75.3%) | 0.50 |
| B. Basic HS + metabolic syndrome | 22 (75.9%) | 86 (88.7%) | 0.08 |
| C. Basic HS + weight gain | 23 (79.3%) | 78 (80.4%) | 0.90 |
| D. Basic HS + diabetes | 21 (72.4%) | 83 (85.6%) | 0.10 |
| E. Basic HS + hyperlipidemia | 21 (72.4%) | 83 (85.6%) | 0.10 |
| F. Basic HS + male sexual dysfunction | 10 (83.3%) | 39 (81.3%) | 0.87 |
| G. Basic HS + female sexual dysfunction | 13 (76.5%) | 41 (83.7%) | 0.51 |
| H. Basic HS + male increased prolactin levels | 10 (83.3%) | 40 (83.3%) | 1.00 |
| I. Basic HS + female increased prolactin levels | 12 (70.6%) | 43 (87.8%) | 0.10 |
| J. Basic HS + akathisia | 22 (75.9%) | 84 (86.6%) | 0.17 |
| K. Basic HS + tardive dyskinesia | 24 (82.8%) | 90 (92.8%) | 0.11 |
| L. Basic HS + other extrapyramidal symptoms | 23 (79.3%) | 91 (93.8%) | 0.02 |
| M. Basic HS + insomnia | 20 (69.0%) | 83 (85.6%) | 0.04 |
| N. Basic HS + somnolence | 21 (72.4%) | 83 (85.6%) | 0.10 |
| O. Basic HS + nausea | 20 (69.0%) | 80 (82.5%) | 0.11 |
| P. Basic HS + vomiting | 21 (72.4%) | 81 (83.5%) | 0.18 |
1Values less than 0.95 indicate willingness to trade in time trade-off choices.
2Based on chi-square analyses comparing caregivers and non-caregivers.
HS = Health state.
ADHD = Attention deficit/hyperactivity disorder.
TTO = Time trade-off.
Health state utilities* (Study 1)
| | | | | | | | | | |
| HS A: Mild Osteoarthritis | 30 | 0.92 (0.06) | 0.75-0.95 | 50 | 0.85 (0.13) | 0.45-0.95 | 0.07 (0.11) | 3.2 | <0.01 |
| HS B: Moderate Osteoarthritis | 30 | 0.84 (0.19) | 0.05-0.95 | 49 | 0.76 (0.23) | 0.00-0.95 | 0.08 (0.22) | 1.6 | 0.11 |
| HS C: Severe Osteoarthritis | 24 | 0.69 (0.28) | 0.15-0.95 | 42 | 0.53 (0.29) | 0.05-0.95 | 0.16 (0.28) | 2.3 | 0.03 |
| HS D: Moderate Osteoarthritis + AE | 30 | 0.82 (0.21) | 0.05-0.95 | 48 | 0.72 (0.26) | 0.00-0.95 | 0.10 (0.25) | 1.8 | 0.07 |
| | | | | | | | | | |
| HS A: Mild Osteoarthritis | 29 | 0.93 (0.05) | 0.75-0.95 | 49 | 0.90 (0.12) | 0.45-0.95 | 0.03 (0.10) | 1.4 | 0.16 |
| HS B: Moderate Osteoarthritis | 29 | 0.89 (0.10) | 0.60-0.95 | 48 | 0.84 (0.20) | 0.25-0.95 | 0.05 (0.17) | 1.5 | 0.13 |
| HS C: Severe Osteoarthritis | 24 | 0.79 (0.19) | 0.35-0.95 | 40 | 0.61 (0.33) | 0.05-0.95 | 0.17 (0.28) | 2.7 | <0.01 |
| HS D: Moderate Osteoarthritis + AE | 29 | 0.88 (0.11) | 0.60-0.95 | 47 | 0.81 (0.23) | 0.15-0.95 | 0.07 (0.20) | 1.7 | 0.09 |
*Based on t-tests comparing means of the two groups. Utility ratings worse than dead are not included in this table. In Study 1, a precise utility value was not obtained when a respondent considered a health state to be worse than dead (i.e., utility < 0). Therefore, participants who considered a health state to be worse than dead have missing data for that health state in this table.
†In Study 1, sample size varied for each individual health state because a specific utility value was not derived if a respondent believed that health state was worse than being dead.
HS = Health state.
AE = Adverse event.
Time trade-off utilities* (Studies 2 and 3)
| | | | | | | | | | |
| A. Adult ADHD, receiving treatment, responder | 47 | 0.87 (0.11) | 0.45-0.95 | 111 | 0.80 (0.19) | −0.05-0.95 | 0.06 (0.17) | 2.7 | <0.01 |
| B. Adult ADHD, receiving treatment, non-responder | 47 | 0.75 (0.21) | 0.05-0.95 | 111 | 0.65 (0.30) | −0.75-0.95 | 0.10 (0.28) | 2.5 | 0.02 |
| C. Adult ADHD, untreated | 47 | 0.73 (0.23) | 0.05-0.95 | 111 | 0.64 (0.30) | −0.65-0.95 | 0.10 (0.28) | 2.2 | 0.03 |
| | | | | | | | | | |
| A. Basic HS (stable schizophrenia, no adverse events) | 29 | 0.68 (0.35) | −0.55-0.95 | 97 | 0.56 (0.45) | −0.75-0.95 | 0.11 (0.43) | 1.3 | 0.21 |
| B. Basic HS + metabolic syndrome | 29 | 0.62 (0.35) | −0.55-0.95 | 97 | 0.44 (0.49) | −0.85-0.95 | 0.18 (0.46) | 1.9 | 0.06 |
| C. Basic HS + weight gain | 29 | 0.64 (0.36) | −0.55-0.95 | 97 | 0.51 (0.47) | −0.85-0.95 | 0.12 (0.45) | 1.3 | 0.19 |
| D. Basic HS + diabetes | 29 | 0.58 (0.39) | −0.55-0.95 | 97 | 0.43 (0.50) | −0.95-0.95 | 0.15 (0.48) | 1.5 | 0.13 |
| E. Basic HS + hyperlipidemia | 29 | 0.61 (0.38) | −0.55-0.95 | 97 | 0.47 (0.47) | −0.85-0.95 | 0.13 (0.45) | 1.4 | 0.16 |
| F. Basic HS + male sexual dysfunction
| 12 | 0.57 (0.29) | 0.05-0.95 | 48 | 0.47 (0.45) | −0.85-0.95 | 0.11 (0.43) | 0.8 | 0.44 |
| G. Basic HS + female sexual dysfunction | 17 | 0.61 (0.43) | −0.55-0.95 | 49 | 0.45 (0.52) | −0.75-0.95 | 0.16 (0.50) | 1.2 | 0.25 |
| H. Basic HS + male increased prolactin levels | 12 | 0.62 (0.27) | 0.05-0.95 | 48 | 0.44 (0.47) | −0.85-0.95 | 0.17 (0.44) | 1.7 | 0.10 |
| I. Basic HS + female increased prolactin levels | 17 | 0.63 (0.41) | −0.55-0.95 | 49 | 0.44 (0.50) | −0.75-0.95 | 0.19 (0.48) | 1.4 | 0.17 |
| J. Basic HS + akathisia | 29 | 0.62 (0.35) | −0.55-0.95 | 97 | 0.43 (0.51) | −0.85-0.95 | 0.19 (0.48) | 2.3 | 0.03 |
| K. Basic HS + tardive dyskinesia | 29 | 0.47 (0.49) | −0.85-0.95 | 97 | 0.25 (0.60) | −0.95-0.95 | 0.22 (0.58) | 1.8 | 0.07 |
| L. Basic HS + other extrapyramidal symptoms | 29 | 0.41 (0.52) | −0.85-0.95 | 97 | 0.25 (0.57) | −0.95-0.95 | 0.16 (0.56) | 1.4 | 0.17 |
| M. Basic HS + insomnia | 29 | 0.65 (0.38) | −0.55-0.95 | 97 | 0.49 (0.47) | −0.85-0.95 | 0.16 (0.45) | 1.7 | 0.09 |
| N. Basic HS + somnolence | 29 | 0.64 (0.36) | −0.55-0.95 | 97 | 0.48 (0.47) | −0.85-0.95 | 0.16 (0.44) | 1.7 | 0.10 |
| O. Basic HS + nausea | 29 | 0.62 (0.44) | −0.65-0.95 | 97 | 0.50 (0.48) | −0.95-0.95 | 0.11 (0.47) | 1.1 | 0.26 |
| P. Basic HS + vomiting | 29 | 0.65 (0.36) | −0.55-0.95 | 97 | 0.45 (0.51) | −0.95-0.95 | 0.20 (0.48) | 2.4 | 0.02 |
*Based on t-tests comparing means of the two groups.
†In Study 3, sample size was smaller for health states representing sexual dysfunction and increased prolactin because each participant rated only the gender-specific health state.
HS = Health state.
ADHD = Attention deficit/hyperactivity disorder.